Pancreatic lipase-related protein 2

BE0004027ProteinHumansPNLIPRP2

Lipase that primarily hydrolyzes triglycerides and galactosylglycerides (PubMed:15287741, PubMed:17401110, PubMed:18702514, PubMed:19451396, PubMed:20083229, PubMed:21865348, PubMed:26494624). It is acted on by 2 drugs in DrugBank.

Gene name
PNLIPRP2
UniProtKB entry
P54317Swiss-Prot
Cellular location
Secreted
Residues / weight
469 residues · 51,960 Da
Also known as
Cytotoxic T lymphocyte lipase · Galactolipase · PL-RP2 · PLRP2 · Triacylglycerol lipase

Resolves to

Protein
UniProtP54317UniProt nameLIPR2_HUMAN
Gene
HGNCHGNC:9157NCBI Gene5408GenBank187232GeneCardsPNLIPRP2
Pharmacology
KEGGhsa:5408
Structure
PDB2OXEPDB2PVS
Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
11GO termsFunction, process and component, as structured annotations
Sign in
2Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Pancreatic lipase-related protein 2, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In